ArticleEJHaem2020

Phase II study of dose-adjusted gemcitabine, dexamethasone, cisplatin, and rituximab in elderly relapsed diffuse large B-cell lymphoma patients.

Satoshi Yamasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.